About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 881 record(s)
Req # A-2019-002069
Adverse Reaction Report (AER) for PANTOPRAZOLE MAGNESIUM. Report numbers: E2B_02897131, E2B_02882249.Organization: Health Canada
May 2020
Req # A-2020-000152
Adverse Reaction Report (AER). Report number: E2B_02851945.Organization: Health Canada
May 2020
Req # A-2020-000027
Adverse Reaction Report (AER). Report number: E2B_02868923.Organization: Health Canada
May 2020
Req # A-2020-000050
Adverse Reaction Report (AER) for DEXLANSOPRAZOLE. Report number: E2B_02969034.Organization: Health Canada
May 2020
Req # A-2020-000063
Adverse Reaction Report (AER). Report numbers: E2B_02928614, E2B_02934756, E2B_02951574.Organization: Health Canada
May 2020
Req # A-2020-000117
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-123505-887, Priorities to Address Aging Information Technology.Organization: Health Canada
May 2020
Req # A-2019-001646
Adverse Reaction Report (AER) for HYDROCHLOROTHIAZIDE, IRBESARTAN. Report number: E2B_02372540.Organization: Health Canada
April 2020
Req # A-2019-001653
Adverse Reaction Report (AER) for PSEUDOEPHEDRINE HYDROCHLORIDE. Report number: E2B_02601741.Organization: Health Canada
April 2020
Req # A-2019-001858
All records which went into the decision to implement of sex/gender tracking for medical device incidents which began in February 2020.Organization: Health Canada
April 2020
Req # A-2019-001595
Adverse Reaction Report (AER) for DEXLANSOPRAZOLE. Report number: E2B_02752874.Organization: Health Canada
April 2020